Sentences with phrase «studies in a clinical environment»

• Perform ultrasound studies in a clinical environment • Provide correct fetal measurements and history • Explain ultrasound procedures to patients and answer questions • Evaluate images for quality and interprete situations and diseases

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

In future studies, scientists will test how the Tongue Drive System performs outside of the controlled clinical environment.

«Involving the GP practices in the Salford Lung Study allowed the team to create an unsupervised environment for the patients, enabling important factors in usual clinical care — such as adherence, frequency of dosing and persistence of good inhaler technique — to rightly influence the trial outcomes.

The GP practices were involved in ensuring the study not only had access to specific COPD patients but also that the usual clinical care provided by the practices was built into the trials — the study was therefore rooted in a real clinical environment unlike tradition efficacy trial model.

Many factors may cause differences between current expectations and actual results including unexpected safety or efficacy data observed during preclinical or clinical studies, clinical trial site activation or enrollment rates that are lower than expected, changes in expected or existing competition, changes in the regulatory environment, failure of Syndax's collaborators to support or advance collaborations or product candidates and unexpected litigation or other disputes.

From these studies, it was evident that there was a differential expression of host neuroimmune genes in the clinical groups, emphasizing the divergent biological environments in the HIV compared to the ODC brain specimens.

Thanks to the exquisite looking leather and shiny metal the inside of the Speed 6e looks like a much more appealing place to be than the clinical environment of most modern cars; it's the automotive equivalent of a wood panelled study in a grand stately home.

Unfortunately, one issue with the current study is that in the «clinical» environment, the experimenters changed three things at once: the size of the enclosure, the size of the litterbox, AND the type of the litter.

Topics Topics All Topics 2014-04-04 ABC News Above the Law Adam G. Klein adjunct professor Administration and Appointments Alumna Press Alumni Hall Alumni press American Theatre Amy Rogers Andrew Coggins Andrew Essick Anne Toomey Anthony Mancini Aol Arts Arts and Entertainment Asian Student Union Associated Press Athletics Athletics and Recreation Audrey Hoover Audrey Rogers Autism Support Network Awards Bennett Gershman Bennett L. Gershman Bisnow Biz Times Bklyner Bloomberg Board of Trustees Books Boston Herald Boston Real Estate Times Brenna Hassinger - Das Broadly Broadway World Bruce Bachenheimer Bruce Barish Business Business Insider Canoe.com Caribbean Life CBS Centers and Institutes Chris Cuddy Christen Cupples Cooper Christine Shakespeare Cindy Kanusher City and State City Newspaper clinical education labs CNBC College of Health Professions College of Health Professions News College of Health Professions Press Columbia Daily Tribune Commencement communications and visual arts Community Health Computing Courier Journal Cyber Press daily news Daily Voice Daily Voice: Pace Professor To Present At World Health Summit In Geneva Damon Dominique Dance Magazine Darren Porcher Darren Rosenblum Darrin Porcher David Caputo David Sharif David Yassky Dean Harriet R. Feldman Delcianna Winders Dena Simmons Diverse Education Diverse Issues documentary Donna Drake Douglas Dillon Dover Post Dr. Jonathan Hill Dyson Dyson News Dyson Press Economic mobility economics Elizabeth Teracino Emily Welty Encore Encore Press Encore Transition Program News Engadget Environment environmental center ENVIRONMENTAL CLINIC STUDY Erica Gollub Euronews Events and Activities Events and Activties Federal Reserve Challenge Team Financial Times Fios1 Fox News Fulbright Award Gary Laermer Gazette George Picoulas Gerontechnology Government and Community Relations grants Gregg Ramsay Harriet Feldman Harriet Feldman Press Hartford Courant Haskins Labs Health health professions Healthcare Hillary Knepper Holly Evans homeland security Hospitality and Tourism Management Houston Chronicle Hudson Valley News Network Huffington Post Ibraiz Tarique Igby Rigney Inside higher ed International Culinary Center IT Jane Kinney Janet Mulvey Jean Coppola Jennifer Magas Jennifer Powell - Lunder Jermaine Cameron Jesse Oxfeld Jessica Bacher Jessica Lynn Jill Backer Jo Franco jobs privacy Joey Wong John Cronin John Nolon John R. Nolon Joseph R. Ficalora Journal News Jr..

The FES is one of the most widely used environment measures in clinical and family research, being identified in over 1400 published research studies (Chipuer & Villegas, 2001; Wise & King, 2008).